Product Name :
Pacritinib
Description:
Pacritinib, also known as SB1518, is a n orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Pacritinib competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and so caspase-dependent apoptosis. JAK2 is the most common mutated gene in bcr-abl-negative myeloproliferative disorders; the JAK2V617F gain-of-function mutation involves a valine-to-phenylalanine modification at position 617. The JAK-STAT signaling pathway is a major mediator of cytokine activity.
CAS:
937272-79-2
Molecular Weight:
472.58
Formula:
C28H32N4O3
Chemical Name:
11-[2-(pyrrolidin-1-yl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.1²,⁶.1⁸,¹²]heptacosa-1(24),2(27),3,5,8,10,12(26),16,21(25),22-decaene
Smiles :
C1OCC=CCOCC2=CC(=CC=C2)C2=CC=NC(NC3=CC1=C(C=C3)OCCN1CCCC1)=N2 |t:3|
InChiKey:
HWXVIOGONBBTBY-ARJAWSKDSA-N
InChi :
InChI=1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3-
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Apabetalone} web|{Apabetalone} Epigenetics|{Apabetalone} Biological Activity|{Apabetalone} Purity|{Apabetalone} custom synthesis|{Apabetalone} Cancer}
Shelf Life:
≥360 days if stored properly.{{Loxapine} web|{Loxapine} GPCR/G Protein|{Loxapine} Technical Information|{Loxapine} In Vitro|{Loxapine} custom synthesis|{Loxapine} Epigenetics}
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.PMID:25040798
Additional information:
Pacritinib, also known as SB1518, is a n orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Pacritinib competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and so caspase-dependent apoptosis. JAK2 is the most common mutated gene in bcr-abl-negative myeloproliferative disorders; the JAK2V617F gain-of-function mutation involves a valine-to-phenylalanine modification at position 617. The JAK-STAT signaling pathway is a major mediator of cytokine activity.|Product information|CAS Number: 937272-79-2|Molecular Weight: 472.58|Formula: C28H32N4O3|Chemical Name: 11-[2-(pyrrolidin-1-yl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.1²,⁶.1⁸,¹²]heptacosa-1(24),2(27),3,5,8,10,12(26),16,21(25),22-decaene|Smiles: C1OCC=CCOCC2=CC(=CC=C2)C2=CC=NC(NC3=CC1=C(C=C3)OCCN1CCCC1)=N2 |t:3||InChiKey: HWXVIOGONBBTBY-ARJAWSKDSA-N|InChi: InChI=1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3-|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥360 days if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|